MedPath

A Trial of Cranberry Capsules for Urinary Tract Infection Prevention in Nursing Home Residents

Phase 3
Completed
Conditions
Bacteriuria
Interventions
Dietary Supplement: 2 cranberry capsules
Dietary Supplement: Placebo
Registration Number
NCT01691430
Lead Sponsor
Yale University
Brief Summary

Urinary tract infection (UTI) is the most common infection in nursing home residents, and bacteriuria is the greatest trigger for antimicrobial therapy in the nursing home setting. The primary aim of this study is to test the efficacy of two oral cranberry capsules per day in the reduction of bacteriuria plus pyuria in female nursing home residents. These aims will be accomplished by conducting a double blind randomized placebo controlled efficacy trial of two oral cranberry capsules daily versus placebo in a cohort of Connecticut female nursing home residents.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
185
Inclusion Criteria
  1. female residents;
  2. long term residents
  3. English speaking; and
  4. age ≥ 65 years.
Read More
Exclusion Criteria
  1. residents that are not expected to be in the nursing home for at least one month (i.e., short term rehabilitation, pending discharge, terminal [life expectancy < 1 month]);
  2. residents who are on chronic suppressive antibiotic or anti-infective (i.e., mandelamine) therapy for recurrent UTI;
  3. residents with end stage renal disease on dialysis (they do not regularly produce urine);
  4. residents unable to produce a baseline clean catch urine specimen for collection;
  5. residents on warfarin therapy because of a potential interaction of warfarin and cranberry juice;
  6. residents with a history of nephrolithiasis because cranberry may increase the risk of nephrolithiasis;
  7. have an indwelling bladder catheter in place;
  8. have an allergy to cranberry products;
  9. are being treated with cranberry products;
  10. residence <4 weeks.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
2 cranberry capsules2 cranberry capsulesExperimental: 2 cranberry capsules
2 placebo capsulesPlaceboExperimental: 2 placebo capsules qd
Primary Outcome Measures
NameTimeMethod
Participants With Urine Cultures With Bacteriuria (>100,000 Cfu/ml or >=100,000 Cfu/ml) Plus Pyuria (Any WBC)One year

Clean catch urine cultures and urinalyses will be obtained every two months for each participant for study purposes.

Secondary Outcome Measures
NameTimeMethod
Number of DeathsOne year
Number of Antibiotic PrescriptionsOne year

Chart review will be performed to determine the names and duration of antibiotic prescriptions prescribed by the primary provider on each participant.

Number of Antibiotic Prescriptions for Suspected UTIOne Year

Chart review will be performed to determine the names and duration of antibiotic prescriptions prescribed by the primary provider on each participant's suspected UTI.

Number of Episodes of Symptomatic UTIOne year

Suspected UTI episodes that are recorded in the medical record by the primary provider will be reviewed by chart review, symptoms will be recorded, and two adjudicators will determine if the definition of symptomatic UTI is met.

Subjects With 1, 2, or 3 Episodes of UTIsOne year

Suspected UTI episodes that are recorded in the medical record by the primary provider will be reviewed by chart review, symptoms will be recorded, and two adjudicators will determine if the definition of symptomatic UTI is met.

Bacteriuria With Multidrug-resistant Gram-negative BacilliOne year

All urine culture data will be reviewed to determine presence of multidrug-resistant gram-negative bacilli (resistance to ≥3 of the following antibiotics: ampicillinsulbactam,cefazolin, ceftriaxone, ceftazidime, fluoroquinolones, piperacillin-tazobactam, meropenem, imipenem, and trimethoprim-sulfamethoxazole).

Number of HospitalizationsOne year

Trial Locations

Locations (21)

Ludlowe Health Care Center

🇺🇸

Fairfield, Connecticut, United States

Water's Edge Center for Health & Rehabilitation

🇺🇸

Middletown, Connecticut, United States

Advanced Nursing & Rehab Center of New Haven

🇺🇸

New Haven, Connecticut, United States

Hughes Health & Rehab Center

🇺🇸

West Hartford, Connecticut, United States

Branford Hills Health Care

🇺🇸

Branford, Connecticut, United States

Northbridge Health Care Center

🇺🇸

Bridgeport, Connecticut, United States

Glastonbury Health Care Center

🇺🇸

Glastonbury, Connecticut, United States

Bridgeport Health Care Center

🇺🇸

Bridgeport, Connecticut, United States

Bridgeport Manor

🇺🇸

Bridgeport, Connecticut, United States

Riverside Health & Rehabilitation Center

🇺🇸

East Hartford, Connecticut, United States

The Nathaniel Witherell

🇺🇸

Greenwich, Connecticut, United States

Avery Heights

🇺🇸

Hartford, Connecticut, United States

Arden House Care and Rehabilitation Center

🇺🇸

Hamden, Connecticut, United States

Hamden Health Care Center

🇺🇸

Hamden, Connecticut, United States

Shady Knoll Health Center

🇺🇸

Seymour, Connecticut, United States

Wadsworth Glen Health Care and Rehabilitation Center

🇺🇸

Middletown, Connecticut, United States

Mary Wade Home

🇺🇸

New Haven, Connecticut, United States

Grimes Center

🇺🇸

New Haven, Connecticut, United States

Lord Chamberlain Nursing & Rehabilitation Center

🇺🇸

Stratford, Connecticut, United States

Village Green of Wallingford

🇺🇸

Wallingford, Connecticut, United States

Abbott Terrace Health Center

🇺🇸

Waterbury, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath